ZYMETX INC
S-3, EX-23.2, 2000-11-09
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: ZYMETX INC, S-3, EX-23.1, 2000-11-09
Next: CV THERAPEUTICS INC, S-3/A, 2000-11-09



<PAGE>   1
                                                                    EXHIBIT 23.2

                         CONSENT OF INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3 No. 333- ___________) and related Prospectus of
ZymeTx, Inc. for the registration of 1,460,068 shares of its common stock and to
the incorporation by reference therein of our report dated October 13, 2000,
with respect to the financial statements of ZymeTx, Inc. included in its Annual
Report (Form 10-KSB) for the year ended June 30, 2000, filed with the Securities
and Exchange Commission.



                                        ERNST & YOUNG LLP

Oklahoma City, Oklahoma
November 8, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission